chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A 16-year-old female patient received TRUMENBA, via an unspecified route of administration, on an unspecified date, at single dose, for immunization; MENVEO, via an unspecified route of administration, on an unspecified date, at unspecified dose, for immunisation and HAVRIX, via an unspecified route of administration, on an unspecified date, at single dose, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever, nausea, nasal congestion, cold like syndrome and weakness all on an unspecified date with outcome of unknown. The information on the lot number has been requested.
I had no cardiac  risk factors , very physically active,  extremely low LDL and developed coronary blockage requiring cardiac stent
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with VARIVAX (Merck) (lot # L017142, expiration date 13-MAY-2017; dose, route not provided. They were improperly stored. No adverse effects were reported. This was one of several reports received from the same source. Additional information has been requested.
Herpetic vesical 2" X 1" surrounded by hot, red area 6" X 8" (injection site left arm) itching, painful.  Symptoms began 24 hours after receiving vaccine.  Treated with VALTREX 1g BID X 5 day.
Patient had a rash (large area) post exposure of PNEUMOVAX admin. MD gave Rx for Doxycycline 100mg and patient will follow up with MD. Advised to contact us as well.
Fever 100.1F, Nausea, Body Aches, and Chills on 1/13.2021.  Nausea lasted 3 hours given Zofran 4mg .  1/14/2021  no longer nauseated no other symptoms at this time.
This is a spontaneous report from a contactable pharmacist. A 20-year-old patient of an unspecified ethnicity and gender received first dose of TRUMENBA, via an unspecified route of administration on 04Aug2017 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced severe reaction of muscle pain on an unspecified date in 2017 that lasted for 3 to 4 days. The outcome of event was recovered on an unspecified date in 2017. Pharmacist wanted to know if they should administer the two-dose schedule or the three-dose schedule in this patient, what does the choice of vaccination schedule with TRUMENBA depend on, and the effectiveness of the two-dose versus the three-dose schedule of TRUMENBA.
The next day in the morning - chills and body aches - started slowly but by mid morning it was more and lasted about 24 hours. In June - shingles symptoms -but  not open lesions. The first doctor I saw (June 14), who wasn't my regular doctor, didn't think it was shingles but then I saw my regular doctor (June 25) and he helped me with meds. I had skin pain and it was rather severe - my whole chest was sensitive to touch and back pain - midline wrapped around my whole rib cage and I had a deep pain in right side of spine in back bothered my sleep and doctor gave me Valacyclovir to treat the shingles and Neurontin for the skin pain/neuroleptic pain I was experiencing. It dissipated over a period of three weeks after getting on the Norantin and I weaned myself off that (took the last on August 1) and finished the course of Acyclovir which was about 7 days.Also in June,  I have had a dry, hacky cough for a long time  and for history : and saw an ENT a couple of times and they told me it was reflux and they put me on Protonix (before the vaccine). I was starting to get more winded then I use to be and and my regular doctor conferred with pulmonologist after an x-ray pulmonologist ( and he ordered a Chest CT and bloodwork and the PFT) for the interstitial lung disease - pulmonologist (July 26th)  - pulmonary function test  (had in July 23 - show no signs of pulmonary fibrosis but my brother and sister both died from it) and bloodwork done. CT scan - showed progression of fibrosis - PFT was negative; bloodwork was for Sogran's and other kind of stuff to attribute to fibrosis on my lungs. CKD3 - Kidney disease - causing some anemia - could attribute to shortness of breath and exercise intolerance. Note: I had a tetanus shot on the 25th of June when I saw my doctor - had a sore arm for a day.
Toxic synovitis 11/15/07-seen in ED, given phenerol.  Persistent toxic synovitis 11/16/07-seen in ED, given phenerol.  Intussusception 11/17/07-air enema reduction.  12/21/07 Reviewed hospital medical records which reveal patient experienced abdominal pain, fever & bloody mucous stool after having several episodes of diarrhea.  Had been seen in ER 11/16 for left hip pain & dx w/toxic synovitis.  Tx w/IV naprosin & d/c to home.  Returned to ER s/p bloody stool.  Admitted 11/17-11/18/2007.  Admitted to surgical service for observation s/p enema reduction. FINAL DX: Intussusception, enema reduced.   2/8/08 Reviewed ER medical records of 11/15/07 which reveal patient experienced left leg pain after nap.  Had received flu shot earlier in day in left arm. Not moving or walking normally.  When lying, kept leg flexed at hip/knee & had significant pain when left hip or knee moved.  Improved w/pain meds but continued to limp at D/C.  To be seen by pcp same day. FINAL ER Dx: pain left leg, etiology undetermined.
Joints in their left hand are swollen, red, and painful; bones hurt; a lot of pain in both legs; left underarm a lump; a lump on inner left thigh; cough that doesn't go away; joints in their left hand are swollen, red, and painful; felt exhausted; crawling sensation in their legs; itch; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (crawling sensation in their legs), PRURITUS (itch), JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt) and PAIN IN EXTREMITY (a lot of pain in both legs) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026021A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included ONE A DAY WOMEN'S.    On 15-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Aug-2021, the patient experienced FORMICATION (crawling sensation in their legs) and PRURITUS (itch). On an unknown date, the patient experienced JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt), PAIN IN EXTREMITY (a lot of pain in both legs), AXILLARY MASS (left underarm a lump), LIMB MASS (a lump on inner left thigh), COUGH (cough that doesn't go away), ARTHRALGIA (joints in their left hand are swollen, red, and painful) and FATIGUE (felt exhausted). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 16-Aug-2021, FORMICATION (crawling sensation in their legs) and PRURITUS (itch) had resolved. At the time of the report, JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt), PAIN IN EXTREMITY (a lot of pain in both legs), AXILLARY MASS (left underarm a lump), LIMB MASS (a lump on inner left thigh), COUGH (cough that doesn't go away), ARTHRALGIA (joints in their left hand are swollen, red, and painful) and FATIGUE (felt exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient is taking is a women's one-a-day multivitamin as concomitant drug
This spontaneous report was received from an unknown reporter via Baxter Health Care Corp (reference # 2015BAX047291) refers to a patient of an unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient felt nauseous after the vaccination with Pneumococcal vaccine(Manufacturer unknown). The outcome of nausea was unknown. The reporter did not provide the relatedness of the event with Pneumococcal vaccine (Manufacturer unknown). Additional information has been requested.
High fever 101.1; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever 101.1) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (High fever 101.1). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (High fever 101.1) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 101.1 (Inconclusive) 101.1 F.         No relevant concomitant medications were reported. Action taken with mRNA-1273(Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Started running a fever 4 hours after injection. Ran a fever of 102 for 10 days. Accompanied by chills, body aches, a cough, and on day 9 and 10 vomiting.  Blood pressure was also erratic, and have been monitoring it for a month, Finally stabilizing 5 weeks later. Also, 6 weeks after the shot, still having Nausea and night sweats. Also a metalic taste in my mouth.
Shortly after vaccine was administered member began to feel weak and heavy. Reports losing feeling in her extremities and having a hard time breathing, felt like heart was racing. Pt was slumped over in her chair but conscious and coherent with staff supporting her upright in chair. A wheelchair was brought and pt assisted in transfer to the wheelchair. Pt was taken to a private observation area. Vital signs were checked and were stable. Pt reported feeling cold and weak. Pt was transferred by staff to a cot and her legs were elevated. She was covered with her jacket and 2 blankets as she began to shiver. Reported tingling and numbness in extremities but had adequate color, good radial and pedal pulses. Reported numbness but able to feel with touched and able to move on command. Spouse was present during evaluation. When pt reported feeling difficulty with breathing but O2 sats were stable at 98-99%. Member was given directions on how to slow her breathing and engaged in conversation. Spouse stated she has a history of syncope and that this happens regularly. Member was brought back at 1021 and by 1051 she was able to sit independently and drink water. She sat in Cot for another 5 minutes and requested to leave. Member was able to stand independently and stably. She walked around observation area and again requested to go home. ER precautions were given to spouse. Spouse stated he would drive her home and in the event of another episode would go to emergency room. Member walked out of facility independently with spouse near by. Member began to feel weak outside facility and dropped to her knees. She remained conscious. Pt refused to return for evaluation and asked to be wheeled to her car. She was breathing at a normal rate and rhythm. No signs of distress. Spouse reported this was not out of the ordinary for her condition and would also like to be released home. Pt was offered several times evaluation which she declined. She was assisted to personal vehicle and left the site.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient received BNT162b2 (BNT162B2), in Apr2021 as dose 1, single (Batch/Lot number: unknown), in May2021 as dose 2, single (Batch/Lot number: unknown) and in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 33 years for covid-19 immunisation. The patient's relevant medical history included: "ulcerative colitis" (unspecified if ongoing); "ADHD" (unspecified if ongoing), notes: ADHD. Concomitant medication(s) included: SULFASALAZINE, start date: Jan2010; ADDERALL, start date: Nov2021; MIRENA, start date: Jan2018. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) COVID rebound, notes: COVID rebound 4 days after completing Paxlovid course. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received other medication Mirena and IUD in 2 weeks product. COVID rebound 4 days after completing Paxlovid course.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The day she received these vaccines, I asked her Dr and CRNP if there were any allergens/ingredients in the vaccines she was to get, that would cause her problems due to her recent reaction to her flu vaccine at 9 months & newly positive egg & dairy food allergies. She left the room, came back & said no they were safe. I trusted her & will never trust anyone like that again. There was egg in the MMR vaccine which I found out as the day went on. About an hour after her vaccines she started having red bump at injection site. She became fussy, upset tummy & diarrhea as the day went on. Did not have anaphylaxis this time but within a few days was covered in a rash, extra bad in her joints & was also all over her body. We did visit the dr again. They diagnosed her with eczema which previously was not a problem at all for her. Swollen joints, reverted to more crawling & less walking. No steroid or ointment, cream would help her skin issues. This went on as a initial flare for over 9 months. She was not consuming any food that I knew was an allergy. She has had more allergy diagnosis years later with periodic flares. Nothing seems to help. Eczema was never a problem until these vaccines. She has suffered since & now seeing an immunologist. This Dr lied about it containing egg, whether it was a lie of omission or ignorance isn?t my concern. She lied & caused my child harm.
Pfizer COVID 19 vaccine that is not working.; Pfizer COVID 19 vaccine that is not working.; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP), Program ID.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Pfizer COVID 19 vaccine that is not working.".  Clinical information: HCP calling in regard to controlant of Pfizer COVID 19 vaccine that is not working. She also mentioned that the call got disconnected and wants to speak to him. Any medical questions addressed by this program forwarded/referred to Medical Information was reported as no.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the available information and close temporal association, a possible causal relationship cannot be excluded between the suspect vaccine BNT162b2 and the reported events drug ineffective, COVID-19.
local injection site pain; rash on her back, torso and/  the inguinal area / was dry / flat circular rash; rash / red; rash was itchy; burning littile bumps; Rash papular; rashes are peeling now; headache; chills; This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number 4749N, expiry date 14th November 2021) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   The patient's past medical history included shingles, rash and stress.   On 15th October 2020, the patient received the 1st dose of Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. In October 2020, less than 2 weeks after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced injection site pain, rash, red rash, itchy rash, burning skin, rash papular, skin peeling, headache and chills. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the injection site pain, rash, red rash, itchy rash, burning skin, rash papular, skin peeling, headache and chills were unknown.   It was unknown if the reporter considered the injection site pain, rash, red rash, itchy rash, burning skin, rash papular, skin peeling, headache and chills to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were as follows: The age at vaccination was not reported. Patient had shingles about 5 years ago and also had history of rashes with increased stress. Physician reported that on 15th  october,2020 patient received the shingrix and flu vaccine and had local injection site pain which resolved in a fewdays. It was reported that a week later patient reported that she had rash on her back, torso and it went down the inguinal area,It was dry, red, itchy, burning littile bumps which progressed to a flat circular rash and the rashes are peeling now. It was also reported that patient had headache and chills after the vaccination. Patient was using Bendryl topically. The reporter consented to follow up
Had a bad reaction to the first dose; Did not get second dose in recommended window; This spontaneous case was reported by an occupational therapist and describes the occurrence of VACCINATION SITE REACTION (Had a bad reaction to the first dose) and PRODUCT DOSE OMISSION ISSUE (Did not get second dose in recommended window) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Had a bad reaction to the first dose) and PRODUCT DOSE OMISSION ISSUE (Did not get second dose in recommended window). At the time of the report, VACCINATION SITE REACTION (Had a bad reaction to the first dose) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not get second dose in recommended window) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was temporarily withheld on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   NO Concomitant medication was reported NO treatment Drug was reported
Hyper vascular inflammation with bulging veins and abdomen pain. Has continued for seven months.
This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a 56-year-old female patient who received SHINGRIX (batch number ML532, expiry date 13th July 2020) for prophylaxis. On 13th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In June 2018, less than a week after receiving SHINGRIX, the patient experienced erythema and pain. On an unknown date, the outcome of the erythema was not recovered/not resolved and the outcome of the pain was recovering/resolving. The reporter considered the erythema and pain to be probably related to SHINGRIX. Additional details were provided as follows: The patient received Shingrix in left arm. The soreness was resolving 1 week after injection, however, redness was still there, it was a 2 by 4 square.
Provider ordered Menactra for administration . This is not in stock at this site and should have been ordered as Menveo. However the medical assistant administered Meningococcal B.  No side effects while in office noted.  No calls after patient left office were received reporting side effects.
red rash, fatigue, malaise diffuse erythematous rash over chest and back  erythema multiforme vs viral exanthum
On 2/13/21 I experienced acute symptoms of Raynauds Syndrome. On 4/12/21 I was diagnosed with herpes zoster opthomalicus, Shingles in my left eye. I now have pseudodendrites and postherpetic neuralgia.
My right arm has been sore since the shot, sometimes pain makes it hard to sleep, can barely reach to tuck my shirt in, my arm hurts that much.
Severe headaches and aching limbs first 3-4 days. Flu like symptoms (aching and felt cold until days 6-7). On day 7 got up with weakness/pins and needles from right elbow to fingertips and lasted about 5 hours till gradually returned to normal. Both eyelids became itchy and swollen. Also pains and aching both legs.After 2 weeks eyelids still droopy -mostly the right eye. Contacted clinic. Advised Walk in which I attended. This was followed by an appointment with my provider and a resulting referral to a neurologist -Dr.; Dr. found problems with my eye muscles and referred me an optometrist where I was seen by a Dr. on 7th June 2021.
Patient received the second dose of the Pfizer-BioNTech vaccine and it was over diluted.  Risk Management was notified, The physician was notified by the nurse immediately, facility was notified, the pharmacy was notified and staff recommended that the patient be revaccinated.  The physician reached out to the patient to monitor.
received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a patient who received Hib (Hiberix) (batch number 242A7) for prophylaxis.   On 28-FEB-2023, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable Hiberix vaccine after a temperature excursion, which led to incorrect storage of vaccine.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Patient reported severe joint pain in hips, knees, and elbows starting within 24 hours of injection which is continuing.
Bruising and petichiae all over body.  Treatment was IVIG and eventually prednisone.
77 year old male with extensive PMhx; recently diagnosed with COVID-19;  8 days ago with fever and weakness and fatigue and cough. HE felt worse and came to ED for evaluation of worsening cough and mild SOB. No chest pain or nausea or vomiting. He is vaccinated
sore throat, nasal congestion, chills,itchy eyes, post nasal drainage starting on 12/26/21